Preliminary Program
IMMUNE-MEDIATED DISEASES
1- General
- Biosimilars: Are rheumatologists and patients ready for transitioning patients from an originator to a biosimilar?
- How to best manage osteoporosis in patients with arthritis.
- How to deal with vaccination of patients with inflammatory arthritis.
2- Rheumatoid Arthritis
- After cancer, which biologic should you use?
- JAK inhibitors should be first line before biologic agents.
- Pregnancy, biologics, and targeted synthetic disease-modifying antirheumatic drugs.
- When is biologic monotherapy the treatment of choice?
3- Spondylarthropathies
- Non-radiographic spondyloarthropathy: If you were paying for it, would you commence biologic therapy?
- Psoriatic arthritis: How to balance management of the skin and the joints
LUPUS, VASCULITIS
- Lupus and pregnancy: Good news for the doctor and the mother.
OSTEOARTHRITIS
- A disease of the bone/subchondral bone? Implication for treatment.
- Inflammation in osteoarthritis as therapeutic target.
- SYSADOA: Effectiveness in treating OA symptoms and maybe more.
- Intraarticular therapy for osteoarthritis: Interesting new findings for patients.
- Management of challenging osteoarthritis cases in daily practice: Well kept secrets.
- Stem cells and other cellular therapies for osteoarthritis.